Filter
1580
Text search:
Field
Operational
Hospital
Featured
155
537
Language
Document type
928
222
191
110
73
25
17
11
2
1
Countries / Regions
115
52
48
46
44
41
40
38
37
36
35
35
35
31
25
24
22
22
21
21
21
18
17
17
17
17
14
14
14
14
13
10
9
9
9
8
7
7
7
7
6
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
740
139
104
84
67
25
14
Toolboxes
119
110
77
68
63
49
49
47
37
36
34
34
32
30
29
24
22
19
16
11
8
8
8
6
3
1
The WHO Cholera Rapid Diagnostic Test (RDT) Target Product Profile outlines the key requirements for developing improved cholera RDTs. It highlights the need for fast, accurate, and easy-to-use tests for early outbreak detection in resource-limited settings. The document sets desired and acceptable
...
Towards Malaria Elimination
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
Accessed November 2017.
Therapeutics Information and Pharmacovigilance Centre | TIPC
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution
...
In 2005, the World Health Organization (WHO) Member States adopted the revised International
Health Regulations (IHR) (2005). The Regulations provide a unique public health framework in the
form of obligations and recommendations that enable countries to better p
...
What We Know, What We Don’t Know, and What We Need to Do
In support of the African decade of disabled persons | 1st January 199 - 31st of December 2009
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
